Comparison of dose distributions using the 3D gamma method is anticipated to provide better indicators for the quality assurance process than the 2.5D (stacked 2D slice-by-slice) gamma calculation, especially for advanced radiotherapy technologies. This study compares the accuracy of the 3D and 2.5D gamma calculation methods. 3D and 2.5D gamma calculations were carried out on four reference/evaluation 3D dose sample pairs. A number of analysis methods were used, including average gamma and gamma volume histograms. We introduce the concept of gamma-angle histograms. Noise sensitivity tests were also performed using two different noise models. The advantage of the 3D gamma method showed up as a higher proportion of points passing the tolerance criteria of 3% dose difference and 3 mm distanceto-agreement (DTA), with considerably lower average gamma values, a lower influence of the DTA criterion, and a higher noise tolerance. The 3D gamma approach is more reliable than the 2.5D approach in terms of providing comprehensive quantitative results, which are needed in quality assurance procedures for advanced radiotherapy methods.
Introduction
Advanced radiotherapy technologies, such as intensity-modulated radiotherapy (IMRT) and volume-modulated arc therapy (VMAT), can provide considerable improvements to the effect of radiotherapy in terms of the therapeutic index. The therapeutic index is the ratio between the advantageous effect of a dose distribution on a tumour, and its damaging effect on surrounding healthy tissues and organs at risk (OAR) (Dewas and Lartigau 2010) . The development and adoption of three-dimensional dosimeters have been driven by the need to optimize the treatment planning and delivery systems of the advanced radiotherapy methods. Therefore, it has been necessary to develop techniques to verify the accuracy of calculated dose plans, validate the functionality of the delivery technologies used, and compare dose distributions produced by different planning methods, such as the models underpinning commercial treatment planning systems (TPSs) and 'first principles' Monte Carlo (MC) calculation algorithms. One of the most widely accepted approaches for comparing dose distributions quantitatively is the γ -evaluation method (Stock et al 2005 , Winiecki et al 2009 , Low 2010 , introduced by Low et al (1998) .
In per-beam quality assurance (QA), false positives may arise, where the 2D γ -test fails to meet passing criteria due to the presence of hot and/or cold areas that exaggerate smaller errors found within the combined dose distributions. On the other hand, false negatives may occur, where the 2D γ -test meets the passing criteria, yet significant dose errors may be exhibited in the combined dose distributions. Therefore, the per-beam planar 2D γ -tests can be impracticable in understanding the clinical significance of dose discrepancies . Furthermore, the 2D γ -analysis used in planar verification for combined dose distributions is dependent on the selected plane of verification. Budgell et al (2005) found no correlation between levels of error in different verification planes. They also found that 2D γ -analysis for the axial plane to be more sensitive to set-up errors than that for the coronal plane.
A QA based on 3D verification is assumed, in principle, to provide a larger number of quality indicators to be analysed, because it covers all three spatial dimensions of the evaluated dose. Also, 3D verification makes it possible to define tolerance criteria in the 3D space in order to account for small setup errors of the dosimeter phantom and/or detector. Full three-dimensional computation of gamma dose parameters is now becoming feasible with the adoption of GPU hardware for numerical computing (Xuejun et al 2011) . Wu et al (2012) demonstrated that the 3D γ can be a feasible pre-treatment QA method for IMRT and VMAT plans. Moiseenko et al (2012) show that the 3D γ -analysis is sensitive to the systematic MLC calibration errors (of greater than 2% change) for planning target volumes (PTVs) and critical structures, particularly for low modulation IMRT plans.
In this study we show that significant false over-estimation can be avoided by taking into account the full 3D neighbourhood of dose points, which will of course positively impact clinical decision processes. We present an evaluation of the 3D γ -method, in terms of its effectiveness compared to the 2.5D γ -calculation method. The 2.5D γ -result was computed for the axial, sagittal and coronal slice orientations, as well as, for the minimum γ -values of the three planes together (3 Plane). In addition, the noise sensitivity of the 3D γ -method was evaluated. Datasets of different radiotherapy plans and MRI gel dosimeter scans were used in the evaluation study.
Theory
The γ -method combines a distance-to-agreement (DTA) criterion with a dose difference criterion through a composite analysis. It measures the closest Euclidean distance γ ( r r ) in the normalized distance-dose space for each reference point r r with all other evaluated points, as given by the following equations:
( r e , r r ) = r 2 ( r e , r r )
where: ( r e , r r ) is the generalized gamma function, computed for each reference point r r with all evaluated positions, r e , r( r e , r r ) is the spatial distance between evaluated and reference dose points, δ( r e , r r ) is the difference between evaluated dose at point r e and reference dose at point r r , d is the DTA criterion representing the maximum accepted distance between a given point in the reference dose and a point in the evaluated dose distribution that receives the same dose, and D is the dose difference criterion that can be either evaluated globally relative to a specific dose value (e.g. the maximum reference or prescribed dose), or locally relative to the dose at the reference point. If the gamma value γ ( r r ) at a given reference point is 1 then it passes the specified acceptance criteria, otherwise it fails. The significance of the γ -evaluation method lies in that it provides a quantitative index indicating the quality of the evaluated points that pass the acceptance criteria, and specifies the degree of disagreement in the regions that fail. In the case of a large spacing between points in the evaluated dose distribution compared to the distance criterion, and where steep dose gradients are present, the evaluated point with the minimum distance to the reference point may not accurately represent the γ -index, rendering a gamma artefact (Depuydt et al 2002) . For this reason, either interpolation can be used in calculating γ -values or the point spacing in the evaluated dose should be less than or equal to 1/3 of d criterion (Low and Dempsey 2003) .
The
where N is the length of the evaluated dose distribution in each dimension, k is the number of dimensions and M is the total number of points in the reference dose distribution. This complexity has hitherto limited the analysis to 2D space. While some authors have proposed techniques for efficient 3D calculation (Wendling et al 2007 , Ju et al 2008 , the analysis is generally carried out on the basis of a slice-by-slice comparison of the reference and evaluated dose volumes. The resultant γ -calculation for each slice can then be stacked up together forming a 2.5D γ -volume.
There are several techniques for interpreting the agreement between two dose distributions using γ -value results, including visual inspection and statistical tools. Visual inspection tools simply display the γ -volume on slice-by-slice basis to be checked by the observer. However, they are subjective and time consuming, especially in evaluating 3D dose distributions. Simple statistical tools (such as the percentage of points where γ 1, and average γ ) fail to provide a detailed analysis of the degree of agreement between the two dose distributions. Using a single value as a QA indicator for an entire dose distribution can conceal dose errors of small regions that are associated with significant clinical implication. Gamma passing rate as a single QA value neither specifies the magnitude of dose discrepancies (Stasi et al 2012) , nor indicates the anatomical location of errors . Gamma histograms (GH) (Low and Dempsey 2003, Spezi and Lewis 2006) can be useful in identifying the proportion of points that pass/fail the acceptable tolerance for each interval of γ -values. The cumulative GH are used for results interpretation in this study.
The γ -vector can be also used to indicate whether its corresponding γ -value is influenced by the dose difference or spatial distance (Low and Dempsey 2003) ; i.e. the higher the dose difference, the more the γ -vector is parallel to the dose axis, and the lower the dose difference, the more the γ -vector is parallel to the spatial axes. This leads to the notion of the γ -angle (Stock et al 2005) as another useful tool for interpreting γ -results. The γ -angle is defined relatively to the dose difference axis, and calculated using the absolute dose and spatial differences in order to be always between 0 and π /2 (as in equation (3)). A γ -angle value of <π /4 indicates a higher influence of the dose difference criterion, while a γ -angle value of >π /4 indicates a higher influence of the DTA criterion and of π /4 indicates an intermediate influence between the dose difference and DTA criteria. The γ -angle can be interpreted as a form of 'influence percentage'; for instance a γ -angle value of 18
• indicates that the gamma value is 20% influenced by the DTA and 80% by the dose difference.
We present in this study the γ -angle histogram (GAH) which we show is a useful tool for indicating the proportion of points influenced by each criterion over a range of intervals between 0 and π /2.
Materials and methods

Calculation of 3D gamma
In this study, the computation time is reduced by limiting the search within a region of interest whose size is defined by the specified DTA criterion. Practically, any evaluated point at a distance greater than 3 × DTA from the reference point can be passed over (Stock et al 2005 , Winiecki et al 2009 , since it is most likely to find the minimum within the boundary of this search window. Because the evaluated points have a uniform sampling over the entire distribution and their spatial location is specified relative to the surrounding points within the search window, a spatial distance array for all r( r e , r r ) is calculated just once, which assists in reducing the overall calculation time (Wendling et al 2007) . Both reference and evaluated dose distributions have a voxel resolution of 1 mm. The γ -calculations are based on a 3% dose difference criterion and a 3 mm DTA acceptance criterion. The dose difference criterion D used in this study is global relative to the maximum value in the reference distribution. A PC equipped with Intel i7 processor was used for calculations. The γ -calculations were performed using the MATLAB computing environment (version R2011a) in conjunction with the C programming language and OpenMP API in order to optimize the speed of the computational processes.
The analysis of γ -results was performed within regions of interest (ROI) of the reference distribution with 20%, 50% and 80% of the maximum reference dose. These ROIs are referred to as ROI 20% , ROI 50% and ROI 80% , respectively. ROI 50% represents the irradiated volume (IRV) and ROI 80% is a surrogate for the PTV. This makes the analysis focus on relevant clinical regions and produce interpretation indicators that are not affected by other dose rate regions. However, the γ -distribution was computed for the entire volumes.
Datasets
Four reference/evaluation 3D sample pairs were included in this study (summarized in table 1). Sample A is an IMRT head and neck (H&N) case with an MC calculated reference plan and an evaluated TPS plan. Sample B is another IMRT H&N case, where the reference distribution was measured using MRI gel dosimetry (Liney et al 2003) in order to evaluate its corresponding TPS plan. Sample C is a standard uniform intensity conformal radiotherapy (CRT) plan which was delivered to two MRI gel dosimeter phantoms; one was stationary during the irradiation as a reference distribution, and the other was moving to simulate human respiration whilst being irradiated as an evaluated distribution. Sample D is similar to sample C, but the moving MRI gel phantom was irradiated at full inhalation using the respiratory gated radiation therapy (RGRT). All the samples share the same size of 256 mm in each direction and a voxel resolution of 1 mm, which forms cubic datasets of 256 3 . As a pre-processing step before computing the γ -distribution, both the reference and evaluation distributions of each sample were 3D smoothed using an averaging filter with a kernel size of 3 3 . The averaging filter can reduce the noise level effectively for dose distributions, especially for those measured using MRI gel dosimetry (Watanabe et al 2004) . The degree of agreement between the dose distributions of each sample is expected to be the highest for sample A (both calculated distributions), and the lowest for sample C (due to the spatial error caused by the moving phantom). Low and Dempsey (2003) examined the 2D γ -distribution behaviour in the presence of data noise and found that the 2D γ -method would be sensitive to noise. In this study we compare the influence of noise on the results produced using both 2.5D and 3D γ -calculations. The TPS plan from sample B was smoothed (averaging filter with a kernel size of 3
Noise model
3 ) and used here as a reference distribution. Two different noise models were imposed on the reference dose distribution to create the evaluation distribution in two tests. In test I, pseudo-random normally distributed noise with zero mean (speckle noise) was used as a multiplicative factor (Low and Dempsey 2003) , simulating the noise present in MC dose calculations. In the second test (test II), additive Gaussian white noise was imposed with zero mean. Gaussian noise is commonly found in medical images, mainly in computed tomography images (Gravel et al 2004) and in bright regions in magnetic resonance images (Paul and Lei 2003) . The two tests were conducted using higher noise levels than usually exhibited in clinical samples (of standard deviations of 1%, 2%, 3%, and higher) to examine the noise sensitivity of 3D γ -calculation compared to 2.5D γ .
Results
Evaluation of 3D gamma
For the entire volume of 256 3 points, the average calculation time was less than 1.2 s for the 3D γ -calculation. The 2.5D γ -calculation took ∼0.28 s for each slice orientation (axial, coronal and sagittal) and ∼0.86 s for the 3 Plane case (the minimum γ -values of the three planes together). Table 2 summarizes the results for the 3D analysis and all 2.5D calculations within the regions of interests ROI 20% , ROI 50% (IRV) and ROI 80% (PTV). It can be noted that the proportion of points passing the acceptance criteria (γ 1) within ROI 20% is higher when using 3D γ -method, with a percentage difference of between 6% and 24% compared with the axial 2.5D γ , and 1.9% to 5.9% when compared with the 3 Plane 2.5D γ (table 3). The average γ -value (γ avg ) is lower for all results evaluated using 3D γ -method than when using 2.5D γ . The γ -histograms in figure 1 show detailed distributions of the γ -values calculated using the axial 2.5D, 3 Plane 2.5D, and 3D γ -evaluation methods within ROI 20% . For reasons of space, in this and subsequent figures and tables we present 2.5D analyses in only the axial Table 2 . Summary of the results computed using 2.5D and 3D γ -evaluation methods for the regions of interests corresponding to 20%, 50% and 80% of the maximum reference dose (ROI 20%, ROI 50% and ROI 80% ). The 2.5D γ was computed for the axial, sagittal and coronal slice orientations, and for the minimum γ -values of the three planes together (3 Plane).
ROI 20%
ROI 50% (IRV) ROI 80% (PTV) The distributions of γ -angle were calculated for each study sample in order to investigate the influencing criterion of the results produced using each method. Table 4 shows that the percentage of γ -points influenced by the DTA criterion is lower for the 3D γ -method than the axial and 3 Plane 2.5D γ -methods in all samples. Figure 2 demonstrates the suggested concept of using the γ -angle histograms. Figure 3 shows the γ and γ -angle results obtained using the 2.5D and 3D γ -calculation methods for the iso-centre slice in sample B. It is clear 2.5D γ (Axial) 2.5D γ (3 Plane) that using the 3D γ -method has reduced the γ -index (especially within the 95% isodose line), and minimized the effect of the DTA criterion in all isodose areas. Table 5 shows the results produced using both 2.5D (axial) and 3D γ -calculation methods in the presence of noise. The 3D γ -calculation method produced a higher percentage of pass points for all noise levels in both tests. In test I, the 2.5D γ -results fail the 90% passing rate of points for an imposed speckle noise on the reference distribution with a standard deviation of 4.5%. In test II, the 2.5D γ -results fail the same criteria but with an imposed Gaussian white noise with a standard deviation of 5%. However, the 3D γ -results for both tests still pass the 90% criterion at the same level of imposed noise. As is shown in table 5, the percentage difference of γ avg increases rapidly for the clinically relevant noise levels between 1% and 2%, and then continues to steadily rise for the higher noise levels.
Noise effect
(a) (b) (c) (d) (e)(f)
Discussion
The 3D gamma calculation method should be expected to produce a more consistent QA measure than 2.5D analysis. In this study we have used samples which ought to show high levels of agreement, and demonstrate that 3D γ produces more reliable evaluations in terms of identifying appropriate quality indicators. The percentage of points passing the DTA and dose difference criteria is relatively higher using the 3D γ -method (p-value ≈0 by paired t-test). This indicates that the likelihood of finding smaller γ -values is enhanced, resulting in increased chance of passing the evaluated criteria and avoidance of over-estimation. For sample A, and within ROI 20% and IRV, the axial and sagittal orientations are more sensitive to the dose differences than the coronal slice orientation. All slice orientations show high agreement rates within the PTV. Given the minimum value of computed 2.5D γ at each point of all slice orientations, the 3 Plane 2.5D γ shows results comparable to that computed using the 3D γ -method. This can be noticed in the GAH for sample A ( figure 2(a) ), where the proportion of points influenced by the dose difference and DTA criteria are very similar for 3 Plane 2.5D γ and 3D γ . As it is shown in table 2, the agreement rates for the 3 Plane 2.5D γ and 3D γ -methods can indicate a high similarity between the plans computed using the MC and TPS methods for sample A, especially within the PTV.
Set-up errors would usually introduce errors in uniform directions that can cause varying sensitivity of slice orientations to dose discrepancies. For sample B, all slice orientations show similar sensitivity to dose discrepancies. Therefore, the high passing rates produced using 3D γ may indicate that the dose discrepancies are more likely to have been introduced by inconsistencies in the polymer gel used for dosimetry rather than that caused by set-up errors or imperfections in gantry, couch and collimator. Less influence of the DTA criterion can be noticed when using the 3 Plane 2.5D γ and 3D γ methods ( figure 2(b) ). Dose errors in sample C are more likely to be caused by the moving phantom during irradiation. The sagittal orientation seems to be slightly less sensitive to the 3D deviation instigated by movement than other slice orientations. This also applies to sample D, albeit higher passing rates are reached due to using the RGRT. For the two samples, the 3D γ passing rates are higher than that for all 2.5D γ forms. This demonstrates the ability of the 3D γ -method to account for 3D deviations caused by phantom movement, which can be seen in the GAHs for both samples (figures 2(c) and (d)) .
Essentially, the γ passing rate should be adopted in conjunction with γ -index distribution and other QA methods such as dose volume histogram, dose difference histogram, and displays for the locations of dose discrepancies. For this reason, the GAH can be used to show how both the influencing criteria are distributed within regions of interest, anatomical structures, or the entire distribution under evaluation. This can be particularly useful when interrogating the sub-regions that fail or pass the γ -test (or that are within a specific γ -index range) in order to provide a simplified distribution of points showing the criterion that mostly influenced γ -values. Accordingly, smaller parts or points within the sub-regions can be investigated using other QA methods and depending on the corresponding influencing criterion. For instance, we can examine the exact locations within the dose distributions of points that are mostly affected by the dose difference criterion to show if they intersect with the OAR region.
The presence of noise in data can impact the closest distance in finding the minimum dose difference and consequently the γ -value (Low 2010) . The 3D γ -evaluation method was shown to be more resistant to noise than the 2.5D γ -method, even for noise levels higher than those usually encountered clinically. The 3D γ -method can be less sensitive to noise levels (standard deviation) of less than 2%. However, the 3D γ passing rate can be around 90% even for higher noise levels of up to 5%.
Conclusions
This study demonstrated how the 3D γ -method can provide more feasible QA indicators when compared with the 2.5D γ -method that was computed for arbitrary slice orientations, and that for the minimum values of computed 2.5D γ at each point of all slice orientations (3 Plane 2.5D γ ). The 3 Plane 2.5D γ -method has a computation time less than that for the 3D γ -method and can produce comparable results to that produced using the 3D γ -method when it is used to compare two calculated distributions with no positioning errors (as in sample A). However, the 3D γ -method can account significantly better for dose discrepancies that may be caused by set-up errors, imperfections in the delivery system, errors in planning algorithms, small arbitrary movements, or inconsistencies in 3D dosimetry methods (as in samples B, C and D).
The γ -angle histogram (GAH) provides a simple yet detailed analysis tool for interpreting γ -results and studying the influencing criteria when comparing 3D dose distributions. The GAH calculations for the 2.5D and 3D γ -methods have demonstrated how the influence of the DTA criterion can be minimized using the 3D γ -method. The 3D γ -calculation method shows a decrease in the effect of the DTA criterion, which is mainly due to extending the search to the 3D space.
The analysis of γ -results was performed within three different regions of interest: ROI 20% , IRV and PTV. An interesting further development of this study would be to investigate how the 3D γ correlates with the organ-specific dose-volume constraints. However, we feel this would be a significant extension of this study and would prefer to consider this for future work.
